MUC5AC and colonic neoplasm: The efficient discrimination of different colorectal polyp subtypes utilizing the novel panel of molecular markers (CA19-9/MUC17/MUC5AC) from the decision tree model, in conjunction with currently available tests and colonoscopy, may aid clinicians in devising improved colon cancer screening recommendations.